Tool to interrogate new class of drugs : comparemela.com

In 2014, the European Medicines Agency approved the drug Tecfidera for the treatment of relapsing multiple sclerosis, a neurodegenerative disease that

Related Keywords

Yi Zhao Sruthi Raja , Jesser Poganik , Saba Parvez , Nature Communications , European Medicines Agency , Cornell University , Professor Yimon Aye , Kuan Ting Huang , Sruthi Raja , Necessary Mediators , Immune Cell Specific Apoptosis Triggered ,